Question 1

Has Tara Mitchell, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $3,205,506 in general payments to Tara Mitchell, MD across 661 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Tara Mitchell, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Tara Mitchell, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Merck	147	$1,927,243
Incyte Corporation	478	$1,193,711
E.r. Squibb & Sons, L.L.C.	23	$59,107
Genentech, Inc.	2	$12,131
Array Biopharma Inc	8	$7,410
Organon	1	$5,805
Iovance Biotherapeutics, Inc.	1	$85
Seagen Inc.	1	$14

Drug	Claims	Cost to plans & patients
Prednisone	11	$68
Levothyroxine Sodium	14	$57

Tara Mitchell, MD

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Medicare billing

Most prescribed under Part D

Other hematology & oncology in Philadelphia